Sigma receptors and neurological disorders

Area of Science:

• Pharmacology
• Neuroscience
• Molecular Biology

Background:

• Sigma receptors are recently identified proteins found in both the central nervous system and peripheral organs.
• Alterations in sigma receptor function or expression are implicated in the pathophysiology of various neurological diseases.
• Numerous sigma receptor ligands are already established therapeutic agents for neurological conditions.

Purpose of the Study:

• To review the diverse roles of sigma receptors, with a specific focus on their involvement in central nervous system disorders.
• To explore the therapeutic potential and current applications of sigma receptor ligands in treating neurological diseases.

Main Methods:

• Literature review of existing research on sigma receptors.
• Analysis of studies investigating the function and expression of sigma receptors in neurological disease models.
• Examination of clinical data on the efficacy of sigma receptor-targeting drugs.

Main Results:

• Sigma receptors play critical roles in neurotransmission and cellular processes within the central nervous system.
• Evidence suggests a strong correlation between sigma receptor dysregulation and the progression of neurological disorders such as Alzheimer's disease, Parkinson's disease, and depression.
• Many clinically used drugs exhibit affinity for sigma receptors, highlighting their therapeutic relevance.

Conclusions:

• Sigma receptors represent a significant and promising target for the development of novel therapeutic strategies for central nervous system disorders.
• Further research into sigma receptor pharmacology and their specific roles in disease pathogenesis is warranted.
• Targeting sigma receptors offers a viable approach to managing a range of neurological conditions.